Tower Research Capital (TRC)’s Innovid Corp. CTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,260
Closed -$6.98K 6012
2024
Q4
$6.98K Sell
2,260
-4,195
-65% -$9.9K ﹤0.01% 4115
2024
Q3
$11.6K Buy
6,455
+2,531
+65% +$4.6K ﹤0.01% 3651
2024
Q2
$7.26K Buy
3,924
+3,624
+1,208% +$7.77K ﹤0.01% 4479
2024
Q1
$747 Sell
300
-951
-76% -$1.65K ﹤0.01% 5388
2023
Q4
$1.88K Buy
+1,251
New +$1.59K ﹤0.01% 5305
2023
Q3
Sell
-288
Closed -$314 6314
2023
Q2
$314 Sell
288
-8,086
-97% -$8.39K ﹤0.01% 5694
2023
Q1
$12K Buy
8,374
+2,290
+38% +$4.18K ﹤0.01% 4141
2022
Q4
$10K Sell
6,084
-1,133
-16% -$3.07K ﹤0.01% 4102
2022
Q3
$20K Buy
7,217
+2,706
+60% +$7.71K ﹤0.01% 3951
2022
Q2
$7K Buy
4,511
+3,178
+238% +$13.7K ﹤0.01% 4840
2022
Q1
$8K Buy
+1,333
New +$7.31K ﹤0.01% 4630
2021
Q4
Sell
-247
Closed -$2K 6664
2021
Q3
$2K Buy
+247
New +$2.44K ﹤0.01% 5314

Tower Research Capital (TRC)'s CTV Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Innovid Corp. (CTV) in Q1 2025, closing a stake of 2,260 shares — an estimated $6.98K sold.

Tower Research Capital (TRC) first reported a position in CTV in Q3 2021 and held it in 12 quarters. The position peaked at $20K in Q3 2022. 0 funds tracked by Wall St. Rank hold CTV as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining Innovid Corp. position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,260 Innovid Corp. shares in Q1 2025, an estimated $6.98K.
  • Tower Research Capital (TRC) first reported a position in Innovid Corp. in Q3 2021 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s Innovid Corp. position peaked at $20K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Innovid Corp. as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.